12:10 EDT Can-Fite BioPharma (CANF) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite BioPharma’s Piclidenoson Shows Promise in Vascular Dementia Treatment
- Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
- Can-Fite BioPharma files to sell 4.9M American depositary shares
- Can-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
- Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum